Skip links

GSS EU Science Funding Gateway

Develop and validate a set of quality of life and patient preference measures for cancer patients and survivors

Summary

Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.

Programme Name

Horizon Europe (2021-2027)

Programme Description

Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.

Programme Details

Call

Develop and validate a set of quality of life and patient preference measures for cancer patients and survivors

Detailed Call Description

The long-term goal of the Mission on Cancer is to support the development of a framework of newly defined, harmonised and systematic surveys, as well as to collect new and update existing quality of life data and registries information, using appropriate digital tools.

Proposals should address all of the following:

  • Conduct analyses of existing quality of life data from studies, surveys and registries together with patients and with a particular focus on patients’ needs, including return to work. These analyses serve to identify problems, fill gaps and validate sets of minimal quality of life measurement tools and approaches for different types of cancer.
  • Set up collaborative approaches with patients, communities and multidisciplinary research teams (for example in the form of living labs, making use of citizen science, social innovation or other participatory research methods). Within this co-design process, quality of life measurement tools and approaches should be developed to capture key elements of quality of life from the perspective of those affected by cancer, which are not captured (adequately) with established metrics.
  • Prepare and conduct a pilot of newly defined, harmonised and systematic quality of life surveys across the EU-27 and Associated countries, reflecting both its diversity (social, cultural, geographic, demographic, health and social protection systems) and unique differences in incidence and mortality of cancer indications. The surveys should gather data using established quality of life metrics and serve to validate the newly developed metrics focusing on cancer, making use of digital tools for data gathering and analysis where relevant.
  • These surveys should form the basis for a comprehensive comparison of the quality of life of cancer patients and survivors across and within countries, as well as between different groups, and prepare the ground for future regular, more extensive high-quality data collection.
  • The influence of age and early-life factors and determinants; genetic risk, socio-economic status; environmental factors; behavioural, including lifestyle risk factors; as well as social, cultural, sex and gender aspects including inequalities (e.g. access to care), should be taken into account across all aspects mentioned above.

 

Financing percentage by EU or other bodies / Level of Subsidy or Loan

100%

EU contribution per project: €11,00 million

 

Eligibility For Participation Notes

The selected beneficiaries must provide the results from the survey, including validation of the metrics, within two years from the start of the project for the purpose of developing EU policies and programmes.

Programme Category
EU Competitive Programmes
Total Budget
€11,00 million
Thematic Categories
  • Health
  • Research, Technological Development and Innovation
Eligibility for Participation
  • Central Government
  • Private Bodies
  • Researchers/Research Centers/Institutions
  • State-owned Enterprises
Call Opening Date
22/12/2021
Call Closing Date
26/04/2022
National Contact Point(s)

Research and Innovation Foundation
29a Andrea Michalakopoulou, 1075 Nicosia
P.O.Box 23422, 1683 Nicosia
Telephone: +357 22205000
Email Address: support@research.org.cy
Website: https://www.research.org.cy/en/

Mr Marinos Fotiadis
Contact Phone: 22 205 048
E-mail: mphotiades@research.org.cy
Website: https://www.research.org.cy/

Dr Ioannis Theodorou
Contact Phone: 22 205 038
E-mail: itheodorou@research.org.cy
Website: https://www.research.org.cy/

(Publish Date: 04/01/2022-for internal use only)

EU Contact Point

European Commission, Directorate-General for Research and Innovation

https://ec.europa.eu/info/departments/research-and-innovation_en#contact

Website
Funding&Tenders HE-Work Programme 2021-2022,Μissions p.54
This website uses cookies to improve your web experience.
Home
Account
Cart
Search
Explore
Drag